State, local and territorial health departments will be awarded part of a $385 million pool in October to strengthen their labs.
The money will be earmarked for increasing labs’ capacities to identify emerging pathogens and patients carrying infectious disease threats, such as antibiotic-resistant bacteria. Outbreaks of such germs have appeared in COVID-19 units throughout the pandemic, the CDC said.
The funds are part of a larger $2.1 billion investment to improve infection prevention and control efforts across the U.S.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
